Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic Shock
Status:
Recruiting
Trial end date:
2023-12-02
Target enrollment:
Participant gender:
Summary
The aim of study is this to evaluate the efficacy and safety of continuous linezolid infusion
versus the standard regimen in treating critically ill patients with septic shock in the ICU